.jpg)
.png)
Spring 2023
The NLA now includes > 2,000 members with representation from physicians, NP/PAs, clinical pharmacists, dietitians, and other healthcare professionals. In this Clinical Feature, we highlight the many ways in which our SWLA/PLA members are pushing boundaries in Clinical Lipidology. Across the NLA... more
“If we wait for the appropriate time to start working, we shall never work; it is better to start with the available means and let the next generation continue what we started”. - Mutaz Al-Khnifsawi, MD Situation Familial hypercholesterolemia (FH) is a common genetic lipid... more
Introduction It’s been over 20 years since the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial1 ushered in the initiation of aggressive LDL-C lowering therapy before hospital discharge for acute coronary syndrome (ACS). Three years later, the Intensive versus... more
Overweight and obesity rates continue to climb worldwide, contributing to significant morbidity and mortality, despite several effective pharmacotherapy treatments that are grossly underutilized. Obesity is a major health problem with a US prevalence of 42.4% in adults and 19.3% in children.1 It... more
Lipid lowering therapy is a cornerstone of cardiovascular risk reduction. However, withholding or stopping lipid lowering therapy may be worth consideration in some individuals. These include elderly patients with comorbidities limiting life expectancy, individuals with a coronary artery calcium... more
The characterization and treatment of severe hypercholesterolemia among patients within large health systems have been studied extensively.1-6 However, little is known about the burden of disease at charity based or community clinics. These types of clinics often provide care for underserved,... more
The Southwest Lipid Association (SWLA) would like to thank all the contributing authors and editors for another edition of LipidSpin. Most importantly, SWLA and its board would like to thank all NLA members for their contributions, pushing boundaries, promoting healthier communities, and fostering... more
As President-Elect of the Pacific Lipid Association (PLA), I am super excited to share with you that the 2023 year is off to a great start! This issue of LipidSpin is a collaboration between PLA and SWLA with a focus on Pushing Boundaries. My immense gratitude goes out to all who have contributed.... more
Dr. Scott Kirkpatrick is SWLA’s 2022 Lipid Scholarship Program recipient, a PGY-5 cardiology fellow at the University of Arizona-Tuscon. As a future general cardiologist with a passion for preventive cardiology, his career mission is to help as many people as he can in the fight against... more
h1.page-header span { font-weight: 700; } New to LipidSpin! Post your completed crossword on social media and tag @nationallipid on Twitter, Facebook, and Instagram! If you are participating in the Pentathlon Challenge, you will earn 60 points for your social post! Click here to ... more